HOME >> BIOLOGY >> NEWS
Most clones doomed from the start, according to Temple University embryologist

Until scientists can improve the early development of cloned embryos, cloning will remain marginally successful, according to research presented today at the American Association for the Advancement of Science (AAAS). Currently, only 1-5 percent of cloned embryos succeed, and many that do succeed are unhealthy.

Keith Latham, Ph.D., Associate Professor of Biochemistry at Temple University School of Medicine, presented the research during the symposium, "Cloning Controversies: Ethics, Science and Society." Latham's presentation, "Somatic Cell-Like Features of Cloned Embryos," highlighted the differences that persist between a normal embryo and a cloned embryo and stand in the way of cloning success.

Contributing to the poor success is the inefficiency and slow rate of reprogramming. Reprogramming is the process whereby cloned embryo genes are turned off and normal embryo genes are turned on, allowing a cloned embryo to develop normally. For some reason, most cloned embryos are unable to make this transformation. Consequently, cloned embryos develop and behave as a hybrid somewhere between an embryo and the adult organism from which it has been cloned.

"Until we learn how to improve the reprogramming of cloned embryos and how to help them transition into a normal, healthy embryo, cloning will remain marginally successful," said Latham.

Latham's research portfolio is focused on reproduction and development at the molecular level. He is currently running four major research projects, all funded by the National Institutes of Health.


'"/>

Contact: Eryn Jelesiewicz
eryn.jelesiewicz@temple.edu
215-707-0730
Temple University
16-Feb-2004


Page: 1

Related biology news :

1. Advance warning of storms and cyclones with new technique
2. Texas A&M clones first cat
3. New study shows normal-looking clones may be abnormal
4. The silence of the clones: new link between DNA replication and silent chromosome architecture
5. Dyslexics not doomed to life of reading difficulties
6. Portrait of a doomed Sea
7. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
8. Mitochondria in spinal cords is ALS target according to UCSD medical researchers
9. Espionage may have driven the evolution of bee language according to UCSD-led study in Brazil
10. Chicken litter harbors agents that generate antibiotic multi-resistance, according to UGA study
11. Governing commons still a struggle, but fight not without hope, according to new report

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage of ... newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and ... synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
Breaking Biology Technology:
Cached News: